Depletion of Dendritic Cells Delays Ovarian Cancer Progression by Boosting Antitumor Immunity
Open Access
- 14 September 2008
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 68 (18), 7684-7691
- https://doi.org/10.1158/0008-5472.can-08-1167
Abstract
Dendritic cells (DC) and cytokines that expand myeloid progenitors are widely used to treat cancer. Here, we show that CD11c+DEC205+ DCs coexpressing α-smooth muscle actin and VE-cadherin home to perivascular areas in the ovarian cancer microenvironment and are required for the maintenance of tumor vasculature. Consequently, depletion of DCs in mice bearing established ovarian cancer by targeting different specific markers significantly delays tumor growth and enhances the effect of standard chemotherapies. Tumor growth restriction was associated with vascular apoptosis after DC ablation followed by necrosis, which triggered an antitumor immunogenic boost. Our findings provide a mechanistic rationale for selectively eliminating tumor-associated leukocytes to promote antitumor immunity while impeding tumor vascularization and to develop more effective DC vaccines based on a better understanding of the tumor microenvironment. [Cancer Res 2008;68(18):7684–91]Keywords
Other Versions
This publication has 37 references indexed in Scilit:
- Tie2-expressing monocytes: regulation of tumor angiogenesis and therapeutic implicationsTrends in Immunology, 2007
- Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapyNature Medicine, 2007
- NK Cells Negatively Regulate Antigen Presentation and Tumor-Specific CTLs in a Syngeneic Lymphoma ModelThe Journal of Immunology, 2007
- The Terminology Issue for Myeloid-Derived Suppressor CellsCancer Research, 2007
- Cytokines, GM-CSF and IFNγ administered by priming and post-chemotherapy cycling in recurrent ovarian cancer patients receiving carboplatinJournal of Translational Medicine, 2006
- VEGF-Induced Adult Neovascularization: Recruitment, Retention, and Role of Accessory CellsCell, 2006
- Resting dendritic cells induce peripheral CD8+ T cell tolerance through PD-1 and CTLA-4Nature Immunology, 2005
- SSX expression in gynecological cancers and antibody response in patients.2004
- NY-ESO-1 and LAGE-1 cancer-testis antigens are potential targets for immunotherapy in epithelial ovarian cancer.2003
- Potential Regulatory Function of Human Dendritic Cells Expressing Indoleamine 2,3-DioxygenaseScience, 2002